PapersFlow Research Brief

Health Sciences · Medicine

Hypertrophic osteoarthropathy and related conditions
Research Guide

What is Hypertrophic osteoarthropathy and related conditions?

Hypertrophic osteoarthropathy and related conditions refer to a cluster of disorders including primary hypertrophic osteoarthropathy, pachydermoperiostosis, digital clubbing, and small intestinal ulceration, characterized by genetic mutations, pathophysiology involving the prostaglandin transporter gene SLCO2A1, and vascular endothelial growth factor, with distinct clinical features and treatment approaches.

This field encompasses 10,987 published works on primary hypertrophic osteoarthropathy and related conditions such as pachydermoperiostosis, digital clubbing, and small intestinal ulceration. Research examines genetic mutations, pathophysiology, clinical features, and treatment options, emphasizing the prostaglandin transporter gene SLCO2A1 and vascular endothelial growth factor. Growth rate over the past 5 years is not available in the provided data.

Topic Hierarchy

100%
graph TD D["Health Sciences"] F["Medicine"] S["Rheumatology"] T["Hypertrophic osteoarthropathy and related conditions"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
11.0K
Papers
N/A
5yr Growth
47.3K
Total Citations

Research Sub-Topics

Why It Matters

Hypertrophic osteoarthropathy and related conditions impact clinical diagnosis and management in rheumatology through identification of genetic and pathophysiological mechanisms. Resnick et al. (1975) described extraspinal manifestations in 21 cases of diffuse idiopathic skeletal hyperostosis (DISH), also known as Forestier's disease, establishing characteristic roentgen abnormalities that aid in recognizing ossifying diathesis beyond spinal involvement. This work supports precise radiographic evaluation in patients with periostosis and related skeletal changes, informing treatment in musculoskeletal conditions.

Reading Guide

Where to Start

"Diffuse Idiopathic Skeletal Hyperostosis (DISH): Forestier's Disease with Extraspinal Manifestations" by Resnick et al. (1975), as it provides a foundational description of extraspinal manifestations in 21 cases with characteristic roentgen abnormalities, offering clear entry into skeletal hyperostosis related to osteoarthropathy.

Key Papers Explained

Resnick et al. (1975) in "Diffuse Idiopathic Skeletal Hyperostosis (DISH): Forestier's Disease with Extraspinal Manifestations" establishes DISH as an ossifying diathesis with spinal and extraspinal features in 21 cases. This connects to broader hypertrophic conditions, though top-cited papers like Hetherington and Ranson (1940) on hypothalamic lesions and Asherson et al. (1989) on antiphospholipid syndrome offer indirect pathophysiological insights into related inflammatory and vascular processes.

Paper Timeline

100%
graph LR P0["Hypothalamic lesions and adiposi...
1940 · 1.0K cites"] P1["Multiple cutaneous and subcutane...
1953 · 711 cites"] P2["Diffuse Idiopathic Skeletal Hype...
1975 · 647 cites"] P3["The “Primary” Antiphospholipid S...
1989 · 963 cites"] P4["Tibial Plateau Leveling Osteotom...
1993 · 668 cites"] P5["Alopecia areata update
2010 · 722 cites"] P6["Genetic Associations with Valvul...
2013 · 944 cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P0 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Current frontiers remain tied to established works on SLCO2A1 mutations and prostaglandin pathways, as no recent preprints or news coverage from the last 12 months or 6 months are available. Focus persists on genetic and clinical correlations without new developments reported.

Papers at a Glance

# Paper Year Venue Citations Open Access
1 Hypothalamic lesions and adiposity in the rat 1940 The Anatomical Record 1.0K
2 The “Primary” Antiphospholipid Syndrome 1989 Medicine 963
3 Genetic Associations with Valvular Calcification and Aortic St... 2013 New England Journal of... 944
4 Alopecia areata update 2010 Journal of the America... 722
5 Multiple cutaneous and subcutaneous lesions occurring simultan... 1953 PubMed 711
6 Tibial Plateau Leveling Osteotomy for Repair of Cranial Crucia... 1993 Veterinary Clinics of ... 668
7 Diffuse Idiopathic Skeletal Hyperostosis (DISH): Forestier's D... 1975 Radiology 647
8 Hypophysectomy and a replacement therapy in the rat 1930 American Journal of An... 553
9 The Parathyroid Glands and Metabolic Bone Disease: Selected St... 1949 JAMA 513
10 Vascular Klotho Deficiency Potentiates the Development of Huma... 2012 Circulation 449

Frequently Asked Questions

What are the key genetic factors in hypertrophic osteoarthropathy?

Mutations in the prostaglandin transporter gene SLCO2A1 play a central role in primary hypertrophic osteoarthropathy and related conditions. These mutations contribute to pathophysiology involving prostaglandin accumulation. The cluster focuses on such genetic associations alongside vascular endothelial growth factor.

What clinical features define pachydermoperiostosis?

Pachydermoperiostosis manifests as part of primary hypertrophic osteoarthropathy with skin thickening, periostosis, and digital clubbing. It presents distinct clinical features tied to SLCO2A1 mutations. Diagnosis relies on these observable signs and genetic confirmation.

How is digital clubbing associated with these conditions?

Digital clubbing occurs in hypertrophic osteoarthropathy and related disorders due to vascular and prostaglandin-related pathophysiology. It serves as a key clinical marker alongside small intestinal ulceration. Research highlights its link to SLCO2A1 dysfunction.

What treatments are explored for these conditions?

Treatment options target pathophysiology from SLCO2A1 mutations and prostaglandin excess in hypertrophic osteoarthropathy. Approaches address clinical features like periostosis and ulceration. Specific therapies remain under investigation within the 10,987 works.

What is the role of vascular endothelial growth factor?

Vascular endothelial growth factor contributes to the pathophysiology of hypertrophic osteoarthropathy and related conditions. It influences vascular changes in digital clubbing and pachydermoperiostosis. Studies emphasize its interplay with SLCO2A1 mutations.

Open Research Questions

  • ? How do SLCO2A1 mutations precisely alter prostaglandin transport to cause periostosis in primary hypertrophic osteoarthropathy?
  • ? What mechanisms link small intestinal ulceration to digital clubbing in these related conditions?
  • ? Can vascular endothelial growth factor inhibitors treat manifestations of pachydermoperiostosis?
  • ? What are the long-term outcomes of extraspinal ossification in diffuse idiopathic skeletal hyperostosis?

Research Hypertrophic osteoarthropathy and related conditions with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Hypertrophic osteoarthropathy and related conditions with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers